A new Cantor Fitzgerald report argues that bitcoin miner Core Scientific is worth far more than the markets believe, thanks to its strategic role in powering AI.

Fortinet, Inc. (NASDAQ:FTNT – Free Report) – Equities researchers at Cantor Fitzgerald issued their FY2026 earnings estimates for shares of Fortinet in a note issued to investors on Monday ...

Cantor Fitzgerald currently has a “Neutral” rating and a $100.00 target price on the stock. The consensus estimate for Fortinet’s current full-year earnings is $2.09 per share.

Marvell Technology, Inc. (NASDAQ:MRVL) received a price target increase from Cantor Fitzgerald on June 18, with the firm raising its estimate to $75 from $60.

Cantor Fitzgerald Poaches 15-Person Team in Germany Push Cantor Fitzgerald LP hired about 15 investment bankers and traders in Germany and is looking to open a new office in the country as it seeks to ...

Investing.com - Cantor Fitzgerald maintained its overweight rating and $96.00 price target on Avidity Biosciences (NASDAQ: RNA) this week. The stock, currently trading at $29.83, has received ...

The analysts at Cantor Fitzgerald have raised their 12-month price target for Coinbase (Nasdaq: COIN) from $253 to $292. Founded in 2012, Coinbase is the largest crypto exchange in the U.S. that ...

On June 11, Cantor Fitzgerald analyst Jonathan Ruykhaver raised the firm’s price target on Zscaler, Inc. (NASDAQ:ZS) to $340 from $290, keeping an Overweight rating on the shares.

Cantor Fitzgerald currently has a “Overweight” rating and a $325.00 target price on the stock. The consensus estimate for Salesforce’s current full-year earnings is $7.46 per share.

On June 18, Cantor Fitzgerald analyst Matthew Prisco began coverage of Microchip Technology Incorporated (NASDAQ:MCHP)’s stock with a “Neutral” rating and a price objective of $70.

MercadoLibre, Inc. (NASDAQ:MELI – Free Report) – Analysts at Cantor Fitzgerald issued their FY2026 earnings per share (EPS) estimates for MercadoLibre in a research note issued to investors on ...

Viking Therapeutics, Inc. (NASDAQ:VKTX – Free Report) – Research analysts at Cantor Fitzgerald issued their FY2026 earnings estimates for shares of Viking Therapeutics in a research note ...